PD-1 Inhibitor Helps Patients With dMMR Tumors Avoid Surgery

(MedPage Today) -- Use of a neoadjuvant checkpoint inhibitor enabled a high proportion of patients with early-stage mismatch repair-deficient (dMMR) solid tumors to avoid surgery and achieve organ preservation in a phase II study.
Among 103 patients...